HepaStem seems most promising pipeline agent for decompensated cirrhosis due to NASH: GlobalData EP News Bureau Sep 13, 2023 HepaStem is a stem cell therapy consisting of liver-derived mesenchymal stem cells (MSC) that addresses different components of…
